{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:02:58Z","timestamp":1785312178418,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ANPCYT\/FONCYT","award":["PICT2007-00539"],"award-info":[{"award-number":["PICT2007-00539"]}]},{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","award":["PIP112 200801 02920\/2009-2012"],"award-info":[{"award-number":["PIP112 200801 02920\/2009-2012"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"UBA","doi-asserted-by":"publisher","award":["PID-UBACYT 01W504\/2011-2014"],"award-info":[{"award-number":["PID-UBACYT 01W504\/2011-2014"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.biopha.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T20:56:18Z","timestamp":1429131378000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Interferon-\u03b2 gene transfer induces a strong cytotoxic bystander effect on melanoma cells"],"prefix":"10.1016","volume":"72","author":[{"given":"\u00darsula A.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Gil-Cardeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela S.","family":"Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana M.E.","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo C.","family":"Glikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2015.04.002_bib0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/B978-0-12-397927-8.00011-7","article-title":"Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations","volume":"65","author":"Somasundaram","year":"2012","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.biopha.2015.04.002_bib0195","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.biopha.2015.04.002_bib0200","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1101\/gad.1437206","article-title":"Malignant melanoma: genetics and therapeutics in the genomic era","volume":"20","author":"Chin","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2015.04.002_bib0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1354\/vp.37-6-597","article-title":"Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases","volume":"37","author":"Ramos-Vara","year":"2000","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.biopha.2015.04.002_bib0210","first-page":"31","article-title":"Naturally occurring translational models for development of cancer gene therapy","volume":"10","author":"Modiano","year":"2006","journal-title":"Gene Ther. Mol. Biol."},{"key":"10.1016\/j.biopha.2015.04.002_bib0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/pcmr.12185","article-title":"Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma","volume":"27","author":"Simpson","year":"2014","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.biopha.2015.04.002_bib0220","doi-asserted-by":"crossref","first-page":"718520","DOI":"10.1155\/2014\/718520","article-title":"Clinical trials of immunogene therapy for spontaneous tumors in companion animals","volume":"2014","author":"Glikin","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.biopha.2015.04.002_bib0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2273","article-title":"Translation of new cancer treatments from pet dogs to humans","volume":"8","author":"Paoloni","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2015.04.002_bib0230","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2000.18.12.2444","article-title":"High- and low dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690\/S9111\/C9190","volume":"18","author":"Kirkwood","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2015.04.002_bib0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jnci\/djq009","article-title":"Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis","volume":"102","author":"Mocellin","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2015.04.002_bib0240","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jnci\/84.15.1185","article-title":"Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta","volume":"84","author":"Johns","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2015.04.002_bib0245","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/jir.2010.0054","article-title":"Gene regulatory and clinical effects of interferon \u03b2 in patients with metastatic melanoma: a phase II trial","volume":"31","author":"Borden","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.biopha.2015.04.002_bib0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4161\/auto.22831","article-title":"IFNB1\/interferon-\u03b2-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function","volume":"9","author":"Ambj\u00f8rn","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2015.04.002_bib0255","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/jir.1996.16.759","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers","volume":"16","author":"Salmon","year":"1996","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.biopha.2015.04.002_bib0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/jir.1996.16.275","article-title":"Why do so many cancer patients fail to respond to interferon therapy?","volume":"16","author":"Einhorn","year":"1996","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.biopha.2015.04.002_bib0265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ymthe.2004.05.027","article-title":"Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein","volume":"10","author":"Benedict","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2015.04.002_bib0270","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000028065","article-title":"Three-dimensional spheroid model in tumor biology","volume":"67","author":"Santini","year":"1999","journal-title":"Pathobiology"},{"key":"10.1016\/j.biopha.2015.04.002_bib0275","first-page":"3719","article-title":"Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341","volume":"6","author":"Frankel","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2015.04.002_bib0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/gt.2009.107","article-title":"Suicide gene therapy on spontaneous canine melanoma: correlations between in vivo tumors and their derived multicell spheroids in vitro","volume":"17","author":"Gil-Cardeza","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2015.04.002_bib0285","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1038\/cddis.2011.58","article-title":"The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance","volume":"2","author":"Barbone","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2015.04.002_bib0290","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/cgt.2012.19","article-title":"Interferon-\u03b2 lipofection II Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-\u03b2 gene transfer to human tumor cells","volume":"19","author":"Villaverde","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2015.04.002_bib0295","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4049\/jimmunol.160.1.328","article-title":"Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas","volume":"160","author":"Gnjatic","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2015.04.002_bib0300","doi-asserted-by":"crossref","first-page":"e5119","DOI":"10.1371\/journal.pone.0005119","article-title":"Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses","volume":"4","author":"L\u00f3pez","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2015.04.002_bib0305","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.cgt.7700682","article-title":"Herpes simplex virus thymidine kinase\/ganciclovir system in multicellular tumor spheroids","volume":"11","author":"Finocchiaro","year":"2004","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2015.04.002_bib0310","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.rvsc.2010.12.012","article-title":"Cytokine-enhanced vaccine and interferon-\u03b2 plus suicide gene as combined therapy for spontaneous canine sarcomas","volume":"91","author":"Finocchiaro","year":"2011","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.biopha.2015.04.002_bib0315","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/S0021-9258(17)41980-6","article-title":"Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations","volume":"269","author":"Felgner","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.04.002_bib0320","first-page":"710","article-title":"Cationic liposome-mediated gene transfer","volume":"2","author":"Gao","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2015.04.002_bib0325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/mr.49.4.398-418.1985","article-title":"Uses of lac fusions for the study of biological problems","volume":"49","author":"Silhavy","year":"1985","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.biopha.2015.04.002_bib0330","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/cgt.2008.53","article-title":"Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect","volume":"15","author":"Zhang","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2015.04.002_bib0335","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/abio.1996.0383","article-title":"An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells","volume":"241","author":"Yang","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2015.04.002_bib0340","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/1087057107306839","article-title":"A reliable tool to determine cell viability in complex 3-D culture: the acid phosphatase Assay","volume":"12","author":"Friedrich","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.biopha.2015.04.002_bib0345","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.0909-8836.1999.eos1070305.x","article-title":"Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis","volume":"107","author":"Depondt","year":"1999","journal-title":"Eur. J. Oral Sci."},{"key":"10.1016\/j.biopha.2015.04.002_bib0350","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.cgt.7701011","article-title":"Adenoviral-mediated interferon alpha overcomes resistance to the interferon protein in various cancer types and has marked bystander effects","volume":"14","author":"Zhang","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2015.04.002_bib0355","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/brain\/awg129","article-title":"Gelatinase B\/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy","volume":"126","author":"Nelissen","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2015.04.002_bib0360","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/107999001750277871","article-title":"Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice","volume":"21","author":"Ahmed","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.biopha.2015.04.002_bib0365","first-page":"1441","article-title":"Significant induction of apoptosis in renal cell carcinoma cells transfected with cationic multilamellar liposomes containing the human interferon-\u03b2 gene through activation of the intracellular type 1 interferon signal pathway","volume":"40","author":"Takaha","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2015.04.002_bib0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.6-1-34","article-title":"Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities","volume":"6","author":"Jonasch","year":"2001","journal-title":"Oncologist"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215000931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215000931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:55:31Z","timestamp":1760093731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215000931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":37,"alternative-id":["S0753332215000931"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.04.002","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03b2 gene transfer induces a strong cytotoxic bystander effect on melanoma cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}